457 related articles for article (PubMed ID: 12734779)
1. Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G; Pedersen SB; Bruun JM; Lihn AS; Jensen PF; Richelsen B
Horm Metab Res; 2003 Mar; 35(3):178-82. PubMed ID: 12734779
[TBL] [Abstract][Full Text] [Related]
2. Plasminogen activator inhibitor type 1 (PAI-1) in plasma and adipose tissue in HIV-associated lipodystrophy syndrome. Implications of adipokines.
He G; Andersen O; Haugaard SB; Lihn AS; Pedersen SB; Madsbad S; Richelsen B
Eur J Clin Invest; 2005 Sep; 35(9):583-90. PubMed ID: 16128865
[TBL] [Abstract][Full Text] [Related]
3. Regional variation in plasminogen activator inhibitor-1 expression in adipose tissue from obese individuals.
Eriksson P; Van Harmelen V; Hoffstedt J; Lundquist P; Vidal H; Stemme V; Hamsten A; Arner P; Reynisdottir S
Thromb Haemost; 2000 Apr; 83(4):545-8. PubMed ID: 10780314
[TBL] [Abstract][Full Text] [Related]
4. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity.
Kolehmainen M; Vidal H; Alhava E; Uusitupa MI
Obes Res; 2001 Nov; 9(11):706-12. PubMed ID: 11707537
[TBL] [Abstract][Full Text] [Related]
5. Difference in leptin mRNA levels between omental and subcutaneous abdominal adipose tissue from obese humans.
Hube F; Lietz U; Igel M; Jensen PB; Tornqvist H; Joost HG; Hauner H
Horm Metab Res; 1996 Dec; 28(12):690-3. PubMed ID: 9013743
[TBL] [Abstract][Full Text] [Related]
6. Expression of TNF-alpha protein in omental and subcutaneous adipose tissue in obesity.
Cao YL; Hu CZ; Meng X; Wang DF; Zhang J
Diabetes Res Clin Pract; 2008 Feb; 79(2):214-9. PubMed ID: 17935818
[TBL] [Abstract][Full Text] [Related]
7. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
Eriksson P; Reynisdottir S; Lönnqvist F; Stemme V; Hamsten A; Arner P
Diabetologia; 1998 Jan; 41(1):65-71. PubMed ID: 9498632
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory cytokines interleukin-6 and oncostatin m induce plasminogen activator inhibitor-1 in human adipose tissue.
Rega G; Kaun C; Weiss TW; Demyanets S; Zorn G; Kastl SP; Steiner S; Seidinger D; Kopp CW; Frey M; Roehle R; Maurer G; Huber K; Wojta J
Circulation; 2005 Apr; 111(15):1938-45. PubMed ID: 15837947
[TBL] [Abstract][Full Text] [Related]
9. Correlation between omental TNF-alpha protein and plasma PAI-1 in obesity subjects.
Cao YL; Wang YX; Wang DF; Meng X; Zhang J
Int J Cardiol; 2008 Aug; 128(3):399-405. PubMed ID: 17698217
[TBL] [Abstract][Full Text] [Related]
10. Regulation of plasminogen activitor inhibitor-1 in human adipose tissue: interaction between cytokines, cortisol and estrogen.
He G; Pedersen SB; Bruun JM; Richelsen B
Horm Metab Res; 2000; 32(11-12):515-20. PubMed ID: 11246818
[TBL] [Abstract][Full Text] [Related]
11. Tumor necrosis factor-alpha-induced production of plasminogen activator inhibitor 1 and its regulation by pioglitazone and cerivastatin in a nonmalignant human hepatocyte cell line.
Takeshita Y; Takamura T; Hamaguchi E; Shimizu A; Ota T; Sakurai M; Kaneko S
Metabolism; 2006 Nov; 55(11):1464-72. PubMed ID: 17046548
[TBL] [Abstract][Full Text] [Related]
12. Metformin, but not thiazolidinediones, inhibits plasminogen activator inhibitor-1 production in human adipose tissue in vitro.
He G; Pedersen SB; Bruun JM; Lihn AS; Richelsen B
Horm Metab Res; 2003 Jan; 35(1):18-23. PubMed ID: 12669266
[TBL] [Abstract][Full Text] [Related]
13. Omental and subcutaneous adipose tissue steroid levels in obese men.
Bélanger C; Hould FS; Lebel S; Biron S; Brochu G; Tchernof A
Steroids; 2006 Aug; 71(8):674-82. PubMed ID: 16762384
[TBL] [Abstract][Full Text] [Related]
14. Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.
Blouin K; Richard C; Brochu G; Hould FS; Lebel S; Marceau S; Biron S; Luu-The V; Tchernof A
J Endocrinol; 2006 Dec; 191(3):637-49. PubMed ID: 17170221
[TBL] [Abstract][Full Text] [Related]
15. Lipoprotein lipase steady-state mRNA levels are lower in human omental versus subcutaneous abdominal adipose tissue.
Panarotto D; Poisson J; Devroede G; Maheux P
Metabolism; 2000 Sep; 49(9):1224-7. PubMed ID: 11016909
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A; Alessi MC; Bastelica D; Geel-Georgelin O; Fina F; Sentocnik JT; Stegnar M; Juhan-Vague I
Diabetologia; 2001 Nov; 44(11):2025-31. PubMed ID: 11719834
[TBL] [Abstract][Full Text] [Related]
17. [Expression of omentin in adipose tissues in obese and type 2 diabetic patients].
Cai RC; Wei L; DI JZ; Yu HY; Bao YQ; Jia WP
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(6):381-4. PubMed ID: 19567114
[TBL] [Abstract][Full Text] [Related]
18. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects.
Lihn AS; Bruun JM; He G; Pedersen SB; Jensen PF; Richelsen B
Mol Cell Endocrinol; 2004 Apr; 219(1-2):9-15. PubMed ID: 15149722
[TBL] [Abstract][Full Text] [Related]
19. Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC; Bastelica D; Mavri A; Morange P; Berthet B; Grino M; Juhan-Vague I
Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1262-8. PubMed ID: 12750120
[TBL] [Abstract][Full Text] [Related]
20. Human epicardial adipokine messenger RNAs: comparisons of their expression in substernal, subcutaneous, and omental fat.
Fain JN; Sacks HS; Bahouth SW; Tichansky DS; Madan AK; Cheema PS
Metabolism; 2010 Sep; 59(9):1379-86. PubMed ID: 20116810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
